Remimazolam alleviates hepatic ischemia-reperfusion injury by activating FOXO1/3 signaling

Abstract Background Hepatic ischemia reperfusion injury (HIRI) frequently gives rise to aggravated liver damage. Currently, there exists a diverse range of anesthetic drugs that possess protective capabilities against ischemia-reperfusion injury (IRI). Nevertheless, the specific functions and underl...

Full description

Bibliographic Details
Published in:BMC Gastroenterology
Main Authors: Bo Zhou, Jian Liu, Lu Jin, Xiaoling Huang
Format: Article
Language:English
Published: BMC 2025-04-01
Subjects:
Online Access:https://doi.org/10.1186/s12876-025-03820-3